PT  - JOURNAL ARTICLE
AU  - Lederman, Lynne
ED  - Fukudo, Shin
TI  - Ramosetron Is Effective in Women With IBS-D
DP  - 2015 Sep 07
TA  - MD Conference Express
PG  - 14--15
VI  - 15
IP  - 14
4099  - http://mdc.sagepub.com/content/15/14/14.2.short
4100  - http://mdc.sagepub.com/content/15/14/14.2.full
AB  - The serotonin 5-hydroxytryptamine receptor antagonist ramosetron reduces symptoms significantly more than placebo in women with diarrhea-predominant irritable bowel syndrome. Ramosetron is effective in women at half the dose required to reduce symptoms in men and has a manageable side effect profile.